Michael Kaseta
CFO and COO; Director · 6 filings · Latest: Apr 14, 2026
HERON THERAPEUTICS, INC. /DE/
Liquidia Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
LQDA | Michael Kaseta | CFO and COO | Apr 15, 2026 | Option Exercise | $2.79 | 86,971 | $242.6K | 483,702 | |
LQDA | Michael Kaseta | CFO and COO | Apr 15, 2026 | Sale | $40.14 | 139,390 | $5.6M | 353,356 | |
LQDA | Michael Kaseta | CFO and COO | Apr 14, 2026 | Sale | $40.00 | 3,000 | $120.0K | 405,775 | |
LQDA | Michael Kaseta | CFO and COO | Apr 14, 2026 | Option Exercise | $2.79 | 3,000 | $8.4K | 408,775 | |
LQDA | MICHAEL KASETA | — | Apr 15, 2026 | Proposed Sale | $38.71 | 139,390 | $5.4M | — | |
LQDA | Michael Kaseta | CFO and COO | Apr 13, 2026 | Sale | $38.37 | 18,958 | $727.4K | 405,775 | |
LQDA | Michael Kaseta | CFO and COO | Apr 10, 2026 | Sale | $40.14 | 23,821 | $956.2K | 411,855 | |
LQDA | Michael Kaseta | CFO and COO | Apr 10, 2026 | Option Exercise | $1.81 | 36,699 | $66.5K | 424,733 | |
LQDA | MICHAEL KASETA | — | Apr 14, 2026 | Proposed Sale | $38.85 | 3,000 | $116.5K | — | |
LQDA | Michael Kaseta | CFO and COO | Apr 9, 2026 | Sale | $40.24 | 133,789 | $5.4M | 411,855 | |
LQDA | Michael Kaseta | CFO and COO | Apr 9, 2026 | Option Exercise | $2.80 | 133,789 | $374.0K | 545,644 | |
LQDA | MICHAEL KASETA | — | Apr 10, 2026 | Proposed Sale | $40.32 | 23,821 | $960.5K | — | |
LQDA | MICHAEL KASETA | — | Apr 9, 2026 | Proposed Sale | $38.19 | 133,789 | $5.1M | — | |
LQDA | Michael Kaseta | CFO and COO | Mar 2, 2026 | Sale | $30.58 | 1,165 | $35.6K | 411,855 | |
LQDA | Michael Kaseta | CFO and COO | Feb 27, 2026 | Option Exercise | — | 2,344 | — | 413,020 | |
LQDA | MICHAEL KASETA | — | Aug 5, 2025 | Proposed Sale | $19.48 | 50,000 | $974.0K | — |